{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:09:55Z","timestamp":1792548595532,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The occurrence of venous thromboembolism (VTE) after abdominal and pelvic cancer surgery increases the risk of mortality and disability. However, there is insufficient evidence supporting the choice of anticoagulation strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched PubMed, The Cochrane Library, Embase, and Web of Science for randomized controlled trials from inception to January 2024. Studies concerning thrombosis prevention after abdominal and pelvic surgery were included. Network meta-analysis(NMA) and direct meta-analysis (DMA) methods were employed to evaluate the efficacy and safety of various prophylactic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty clinical trials involving a total of 4923 patients were included. The DMA results showed that low molecular weight heparin (LMWH) was more effective in preventing VTE compared to no treatment (OR = 1.96; 95% CI: 1.21 to 3.19), and LMWH plus physiotherapy was more effective than LMWH (OR = 10.95; 95% CI: 1.33 to 90.40). The NMA results indicated that DOACs (OR = 0.34; 95% CI: 0.11 to 0.76) and LMWH (OR = 0.51; 95% CI: 0.32 to 0.77) were significantly effective in preventing venous thrombosis compared with no treatment. The cumulative ranking probability curve (SUCRA) showed that direct oral anticoagulants (DOACs) were the best intervention. In terms of major bleeding, unfractionated heparin (UFH) had a higher risk than LMWH, physiotherapy, and no treatment, with statistically significant differences. The SUCRA analysis indicated that physiotherapy was the best intervention for major bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Existing evidence suggests that DOACs can provide better thromboprophylaxis efficacy for patients after abdominal and pelvic cancer surgery, achieving an optimal balance between efficacy and safety. LMWH has become an intervention with efficacy second only to DOACs, with similar safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link><jats:bold>, identifier CRD42024513090<\/jats:bold>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1445485","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:30:09Z","timestamp":1739273409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of efficacy and safety of thrombus prevention strategies after abdominal and pelvic cancer surgery: Bayesian network based meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Shiran","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henghai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoru","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(07)70130-5","article-title":"Thrombophilia and risk of venous thrombosis in patients with cancer","volume":"120","author":"Decousus","year":"2007","journal-title":"Thromb Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-8179.2019.13.765","article-title":"Guidelines for prevention and treatment of tumor-associated venous thromboembolism","volume":"46","author":"Ma","year":"2019","journal-title":"Chin J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0164","article-title":"Venous thromboembolism prevention in cancer outpatients","volume":"11","author":"Khorana","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-03-0189","article-title":"Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy","volume":"94","author":"Kakkar","year":"2005","journal-title":"Thromb Haemost"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31821b98da","article-title":"Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis","volume":"254","author":"Merkow","year":"2011","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020259","article-title":"Venous thromboembolism and cancer: A comprehensive review from pathophysiology to novel treatment","volume":"12","author":"Canonico","year":"2022","journal-title":"Biomolecules"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0053","article-title":"Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Go","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0047","article-title":"Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Streiff","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.16073\/j.cnki.cjcpt.2022.10.01","article-title":"Expert consensus on the prevention of venous thromboembolism in perioperative period for gynecologic tumor patients","volume":"29","author":"Wang","year":"2022","journal-title":"Chin J Cancer Prev Treat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015796","article-title":"Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer","volume":"140","author":"Becattini","year":"2022","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10760296221132556","DOI":"10.1177\/10760296221132556","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after major gynecological cancer surgery: the VALERIA trial","volume":"28","author":"Longo de Oliveira","year":"2022","journal-title":"Trial. Clin Appl Thromb Hemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic Malignant neoplasm: A randomized clinical trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23736\/S0392-9590.23.05177-5","article-title":"Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence","volume":"43","author":"Icolaides","year":"2024","journal-title":"Int Angiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)91205-x","article-title":"Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin","volume":"145","author":"Clarke-Pearson","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(84)90030-1","article-title":"Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial","volume":"18","author":"Clarke-Pearson","year":"1984","journal-title":"Gynecol Oncol"},{"key":"B19","article-title":"Complications of low-dose heparin prophylaxis in gynecologic oncology surgery","volume":"64","author":"Clarke-Pearson","year":"1984","journal-title":"Obstet Gynecol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1988.tb01268.x","article-title":"Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery","volume":"18","author":"Fricker","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"B21","article-title":"A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis","volume":"75","author":"Clark-Pearson","year":"1990","journal-title":"Obstet Gynecol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90360-u","article-title":"A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery","volume":"168","author":"Clarke-Pearson","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(01)01601-5","article-title":"Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial","volume":"98","author":"Maxwell","year":"2001","journal-title":"Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.09.009","article-title":"Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study","volume":"125","author":"Sakon","year":"2010","journal-title":"Thromb Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03892.x","article-title":"Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study","volume":"8","author":"Kakkar","year":"2010","journal-title":"J Thromb Haemost"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3893-1","article-title":"Optimal prophylactic method of venous thromboembolism for gastrectomy in Korean patients: an interim analysis of prospective randomized trial","volume":"21","author":"Song","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12740","article-title":"Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic Malignancy","volume":"41","author":"Nagata","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"B29","article-title":"Efficacy of venous thromboembolism prophylaxis in patients undergoing pelvic cancer surgery: a randomized controlled trial","volume":"100","author":"Pootracool","year":"2017","journal-title":"J Med Assoc Thai"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.12279","article-title":"Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery","volume":"3","author":"Hata","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00595-019-01859-w","article-title":"Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404)","volume":"50","author":"Nakagawa","year":"2020","journal-title":"Surg Today"},{"key":"B32","article-title":"Elastic stockings plus enoxaparin and intermittent pneumatic compression in preventing postoperative deep venous thrombosis in patients with ovarian cancer","volume":"13","author":"Zhou","year":"2020","journal-title":"Int J Clin Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/bjs5.50323","article-title":"Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal Malignancies: multicentre randomized clinical trial","volume":"4","author":"Kamachi","year":"2020","journal-title":"BJS Open"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002690","article-title":"Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients","volume":"128","author":"Ho","year":"2013","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7326\/M21-0717","article-title":"Risk for recurrent venous thromboembolism and bleeding with apixaban compared with rivaroxaban: an analysis of real-world data","volume":"175","author":"Dawwas","year":"2022","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1445485\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T11:30:14Z","timestamp":1739273414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1445485\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":35,"alternative-id":["10.3389\/fonc.2025.1445485"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1445485","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"article-number":"1445485"}}